Company Overview
Asset Reconstruction Company (India) Limited operates as an asset reconstruction company, acquiring and resolving distressed assets and non-performing loans. The company acquires, manages, and resolves stressed assets across corporate, SME, and retail segments, providing asset reconstruction services that include acquisition of non-performing assets, restructuring, settlement, and sale of assets. It conducts property auctions, manages settlement processes related to distressed assets, and engages in insolvency and bankruptcy resolution processes under the Insolvency and Bankruptcy Code, 2016, in partnership with insolvency professionals and legal firms. The company also undertakes corporate social responsibility initiatives focused on education, vocational skills, livelihood enhancement, and environmental sustainability. The company serves corporate, SME, and retail clients with stressed assets, as well as banks, non-banking financial companies, legal professionals, advocates, and law firms involved in asset recovery and insolvency processes. The company was founded in 2002 and is based in Mumbai, India. Asset Reconstruction Company (India) Limited operates as a subsidiary of Avenue India Resurgence Pte Limited.
Why Investors Should Care
Revenue has grown at a 10.1% CAGR over the past five years.
Trades at a P/E of 13.5, below the sector median of 17.0.
Maintains a net profit margin of 59.2%.
Carries low leverage with a debt-to-equity ratio of 0.32.
Recent Developments
- Mar 2026 Revenue of ₹320.57 Cr (-0.8% YoY); net profit ₹351.69 Cr.
- Trailing 12 Months Year-on-year growth — revenue -0.8%, earnings +6.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.1%, profit CAGR 7.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.12% |
| 1 Year: | -0.84% |
Compounded Profit Growth
| 5 Years: | 7.06% |
| 1 Year: | 6.73% |
Stock Price Performance
| 1 Year: | - |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
P/E of 13.51 is below the sector median of 17.01 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 59.2%.
- Compounding revenue at 10.1% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ARCIL ARCIL.NS NSEFINANCIAL | 137.02 | 13.51 | ₹4,451.74 Cr | 0.00% | 12.03% | 11.23% | 10.12% | 7.06% |
| 2 | HDFCBANK HDFC Bank Limited NIFTY50NSEAIFINANCIAL | 721.50 | 15.76 | ₹11.12 L Cr | 1.85% | - | 13.84% | 16.90% | 12.47% |
| 3 | ICICIBANK ICICI Bank Limited NIFTY50NSEAIFINANCIAL | 1,358.80 | 17.56 | ₹9.75 L Cr | 0.86% | - | 16.07% | 18.11% | 16.78% |
| 4 | SBIN State Bank of India NIFTY50NSEAIFINANCIALPSU | 991.40 | 10.60 | ₹9.15 L Cr | 1.72% | - | 15.18% | 12.19% | 14.39% |
| 5 | BAJFINANCE Bajaj Finance Limited NIFTY50NSEAIFINANCIAL | 1,006.20 | 30.89 | ₹6.26 L Cr | 0.51% | - | 16.68% | 22.58% | 18.23% |
| 6 | KOTAKBANK Kotak Mahindra Bank Limited NIFTY50NSEAIFINANCIAL | 415.00 | 20.32 | ₹4.13 L Cr | 0.16% | - | 10.64% | 13.48% | 8.92% |
| 7 | AXISBANK Axis Bank Limited NIFTY50NSEAIFINANCIAL | 1,241.00 | 13.96 | ₹3.86 L Cr | 0.08% | - | 13.35% | 12.16% | 34.61% |
| 8 | BAJAJFINSV Bajaj Finserv Ltd. NIFTY50NSEAIFINANCIAL | 1,837.00 | 29.08 | ₹2.94 L Cr | 0.07% | - | 12.58% | 22.92% | 15.16% |
| 9 | LICI Life Insurance Corporation of India NIFTY_MIDNSEFINANCIALPSU | 395.50 | 8.33 | ₹2.50 L Cr | 2.43% | - | 32.53% | 7.26% | 16.86% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 240.06 Cr | 323.19 Cr | 323.29 Cr | 320.57 Cr |
| Cost of Revenue | 51.39 Cr | 51.79 Cr | 56.79 Cr | 55.54 Cr |
| Gross Profit | 188.67 Cr | 271.40 Cr | 266.50 Cr | 265.03 Cr |
| Operating Expenses | 56.06 Cr | 89.24 Cr | -58.87 Cr | -94.83 Cr |
| Operating Income | 132.61 Cr | 182.16 Cr | 325.37 Cr | 359.86 Cr |
| EBITDA | 390.07 Cr | 424.04 Cr | 445.80 Cr | 504.61 Cr |
| Interest Expense | 1.60 Cr | 7.37 Cr | 12.49 Cr | 36.18 Cr |
| Pretax Income | 386.33 Cr | 414.74 Cr | 431.16 Cr | 464.57 Cr |
| Tax Provision | 82.39 Cr | 103.85 Cr | 121.92 Cr | 141.88 Cr |
| Net Income | 286.60 Cr | 330.46 Cr | 329.51 Cr | 351.69 Cr |
| Diluted EPS | 8.82 | 10.17 | 10.14 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Total Assets | 2,789.58 Cr | 3,656.69 Cr | 4,395.98 Cr | 5,726.40 Cr |
| Current Assets | 1,910.53 Cr | 2,954.32 Cr | 3,359.88 Cr | 4,085.78 Cr |
| Cash & Equivalents | 244.27 Cr | 359.26 Cr | 183.25 Cr | 158.16 Cr |
| Inventory | - | - | - | - |
| Receivables | 44.75 Cr | 6.12 Cr | 9.28 Cr | 61.28 Cr |
| Total Liabilities | 545.42 Cr | 1,230.18 Cr | 1,732.85 Cr | 2,771.18 Cr |
| Current Liabilities | 64.68 Cr | 163.73 Cr | 356.65 Cr | 1,565.35 Cr |
| Long Term Debt | 118.01 Cr | 50.00 Cr | 75.00 Cr | 386.56 Cr |
| Total Debt | 118.01 Cr | 151.34 Cr | 306.56 Cr | 1,205.49 Cr |
| Total Equity | 2,811.63 Cr | 3,076.14 Cr | 3,418.01 Cr | 3,781.21 Cr |
| Shares Outstanding | 32.49 Cr | 32.49 Cr | 32.49 Cr | 32.49 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating Cash Flow | 295.32 Cr | 550.72 Cr | 283.47 Cr | 193.83 Cr |
| Investing Cash Flow | -363.30 Cr | -380.60 Cr | -553.66 Cr | -985.18 Cr |
| Financing Cash Flow | -43.51 Cr | -55.13 Cr | 94.17 Cr | 766.26 Cr |
| Capital Expenditure | -83.40 L | -4.40 Cr | -1.55 Cr | -1.80 Cr |
| Free Cash Flow | 294.49 Cr | 546.32 Cr | 281.93 Cr | 192.02 Cr |
| Net Change in Cash | -111.48 Cr | 114.99 Cr | -176.01 Cr | -25.09 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Margin % | 78.6% | 84.0% | 82.4% | 82.7% |
| Operating Margin % | 55.2% | 56.4% | 100.6% | 112.3% |
| Net Margin % | 119.4% | 102.3% | 101.9% | 109.7% |
| ROE % | 10.2% | 10.7% | 9.6% | 9.3% |
| ROCE % | 4.9% | 5.2% | 8.1% | 8.6% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARCIL
Arcil shares make flat debut at issue price on NSE, BSE; should you buy, sell or hold? - Moneycontrol.com
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPXzljOThVRTQyamFaNXRha0xoX2ZKTW8yT2M2eEFiaTJoQ3cwbGdFRmF5c3liZGNNdGF2cEhtRjFabGFLZ3RuMzd3WVcyOVVLb01fVlk2X0NSUFh0eGtocFAza3VyNk5qdjJQaHZ4eEdlZ1htZ2M5d19vaEMtYkcyOUMtWjNQNDJBdEEtY0…
Asset Reconstruction Company (India) Limited Stock (ARCIL) - Quote NSE India S.E. - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNZURaR2tMM0xUanhtbjlZb3oxcXJOY2NwdWNJNFVVV3daeUpNVl9PMjc1dnJsYjZCZVpzanBMclNTTWxTcUVESlE4bjhSaDVNYXBmTGVTdUQyX2oxeU1DTDgtci0tMlMwdTVfZk1jajBPcW9aWFJpTXVhSjRLcFduTkNHWmg5QQ?oc=5" t…
ARCIL shares list at IPO price of ₹139 on NSE and BSE - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQVDBTVnNoU0ZHanJhNUdWSTB6eW1kcWg0aFd0SERLTHp1M0Z6U2dPR0xtdWp1VFNlYzloQzN6VDJRVjFTeGNZZ05obkt2VkZJQ21nR0E2Z1FGZmRVT3lhVjRQRXpHVGozMVA2UzFsczdNOUhQZGhwQllHV1VzOG9TMnZEN3QwVlZpNHY1SX…
ARCIL Shares List Flat At Rs 139 Despite 20x IPO Subscription - BW Businessworld
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOUxDM090YXNQSHA3eWo2ZTU2bHNwZ3BESTQ5TWFNUkZEZjdNR0wwdzJVU1RIZlktTGV0S0QwVVk5NWdkZHBnUVR5bDViSS1DcFB1QTNSM0xVNVBuLXg1bGhpekFUd3NEaTRlX0s4blJ1b3hSTExYRjhCVzJSM2N6MXZNMnRrSmxzbzhybj…
ARCIL Shares List Flat at Rs 139 After Rs 733 Cr IPO - HDFC Sky
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQT1RTQWxkMXJJallwSGdmZFVfRE84c0ZSby1xQnlWa1FyUUtoMVN4TV90TnNaV21CQzAySEpNd2hzcnZlQXVmdGxzZk1TNHFyV2pBek1RdWNqaTZuQkxBNmhMWTlNVXpZM3ZFckVoWkJpSHA2YkV4WFZTUmFzM3pNWnlMU3o?oc=5" targ…
Arcil IPO Allotment: How to check status on BSE, NSE, MUFG Intime India - IndiaIPO
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQaUJYUkdZazB1LV92MmxaLVJiU1FGOGNBUFVwR3NPUzlPM04zcWl1bWhPQm01ZXZORjNrQkpNOTV3RE1WSjBfZmV0dXROU2FpLWljZ0RCaUpOanZrcUdJNGtPcGJtSmlWeXVjWXg0ZzROZXBXY0ZaS3hqRFM0ZVh0bG9wT3RBUUdqaGFwTU…
ARCIL — Frequently Asked Questions
What is the current share price of ARCIL?
As of 2026-09-18 04:56 IST, ARCIL trades at ₹137.02 on NSE. Its 52-week range is ₹137.02 to ₹137.02.
What is the market capitalisation of ARCIL?
ARCIL has a market capitalisation of ₹4,451.74 Cr on NSE.
What is the P/E ratio of ARCIL?
ARCIL trades at a trailing price-to-earnings (P/E) ratio of 13.51. The industry average P/E is 17.01. Its price-to-book (P/B) ratio is 1.18.
What is the return on equity (ROE) of ARCIL?
ARCIL has a return on equity (ROE) of 11.23%. Its return on capital employed (ROCE) is 12.03%.
Is ARCIL a good stock to buy?
This page provides a data-driven analysis of ARCIL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.